Navigation Links
Hypertensives could benefit regular alcohol consumption

A recent study reported by researchers in the Journal of Hypertension indicates that hypertensive patients could reduce their cardiovascular morbidity and improve their atherosclerotic risk profile by consuming alcohol on a regular basis. The researchers indicated that serum lipoprotein(a), a powerful predictor of organ damage, was reduced with regular alcohol consumption. The researchers studied 402 patients with untreated essential hypertension to assess the links between drinking// and serum lipoprotein(a) over a wide range of alcohol intake levels. They also investigated whether the association between alcohol intake and serum lipoprotein(a) concentrations occurred over the whole spectrum of apo(a) phenotypes.

The investigators found that there was no difference in lipoprotein(a) concentrations between teetotallers and occasional drinkers. However, they found that median lipoprotein(a) concentrations were 21% lower in light drinkers (those consuming up to 20 grams of ethanol daily), 26% lower in moderate drinkers (21-50 grams daily) and 57% lower in heavy drinkers (over 50 grams daily) when compared to teetotallers and occasional drinkers. These findings were similar to both men and women. They also studied the frequency distributions of apo(a) isoforms and liver function parameters and log lipoprotein(a) concentrations. They found that the former were comparable across these intake groups while the latter(log lipoprotein(a)) were inversely and independently correlated with alcohol consumption in hypertensives of both sexes.

Researchers concluded that lipoprotein(a) is inversely and dose-dependently related to alcohol intake in hypertensive patients, and that this relationship was independent of the size distribution of apo(a) isoforms.


'"/>




Page: 1

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Beware of the oral patch! It could be cancer!!!
3. Prozac miracle could end in disaster
4. Wonder drug - could end in disaster
5. Pollution could be a risk
6. Fright could be more harmful
7. Pregnant smokers could harm their child
8. Snoring could be a warning
9. Anthrax drug doxycycline could stunt fetal growth
10. Hike in drug licence fee could hit several SSI units in TN
11. Lengthy Fingers could predict heart attacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald ... officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio University ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President ... later this year. Dyer started as the Chairman of the Management Committee when ... of the corporation including the recruitment of investor/owners and development of the business plan. ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 23, 2017 Non-alcoholic steatohepataitis (NASH) ... various drugs being developed for the treatment ... drugs that are in various phases of ... focuses on novel pharmacologic drugs & regenerative ... therapies, recombinant proteins and RNA-based therapeutics, but ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
Breaking Medicine Technology: